Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rail Vision Announces Second Half and Full Year 2024 Financial Results: Reports Strong Revenue Growth for the Full Year 2024, Driven by Key Orders and Market Expansion
-
Nova LifeStyle Announces Fiscal 2024 Financial Results
-
Zevra Therapeutics Files Preliminary Proxy
-
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2024
-
FRP Holdings Announces Investor Day, Conference Participation and its New Investor Website and Presentation
-
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
-
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
-
Archimedes Tech SPAC Partners II Co. Announces the Separate Trading of its Ordinary Shares and Warrants Commencing April 3, 2025
-
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Operational Highlights
-
IDEX Biometrics ASA - Information about the second exercise period for warrants (Warrants B) issued in connection with the Private Placement and Subsequent Offering
-
Wendel completes the acquisition of a controlling stake in Monroe Capital LLC, a transformational transaction in line with its strategic roadmap
-
Wintrust Financial Corporation Announces First Quarter 2025 Earnings Release Schedule
-
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates
-
Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
-
Rekor Systems Reports Strong 2024 Financial Results Highlighted by Record Revenue and Significant Operational Improvements
-
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
-
Open Lending Reports Fourth Quarter and Full Year 2024 Financial Results
-
Birchtech Reports Fourth Quarter 2024 Financial Results
-
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
-
Pathfinder Bancorp, Inc. Declares Dividend
-
Compass Therapeutics to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer
-
Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
-
Aqua Metals Reports Milestone Advancements, Strategic Progress, and Sierra ARC Lithium Battery Recycling Campus Developments in 2024
-
Equity Stock Transfer teams up with Newsmax Inc. for historic IPO opening on New York Stock Exchange’s main board
-
MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
-
Applied Digital Sets Fiscal Third Quarter 2025 Conference Call for Monday, April 14, 2025, at 5:00 p.m. Eastern Time
-
Expion360 Reports Fourth Quarter and Full Year 2024 Financial Results
-
Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma
-
Progress Announces First Quarter 2025 Financial Results
-
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
-
Revolution Medicines to Participate in April 2025 Investor Conferences
-
INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results
-
Open Lending Announces Leadership Changes
-
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
-
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update
-
American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Bank OZK Announces Date for First Quarter 2025 Earnings Release and Conference Call
-
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
-
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
-
Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
Helport AI Reports First Half Fiscal Year 2025 Financial Results
-
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025
-
SAML Announces Strategic Review and Operational Streamlining of Public Safety Businesses and Shareholder Meeting Date.
-
Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
-
Red Cat Holdings Reports Financial Results for the 2024 Transition Period (as of December 31, 2024 and the eight months then ended) and Provides Corporate Update
-
Yoshiharu Regains Compliance with NASDAQ Stockholders’ Equity Requirement
-
GDEV announces results for the fourth quarter and full year 2024
-
Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion
